BriaCell Therapeutics Corp. (BCTX) AI Dilution Summary

Cash was $22,804,425 at 2026-04-30 against estimated monthly burn of $2,521,384. The most recent capital raised was a registered direct offering closed 2026-06-02: 1,449,300 shares at $3.25 per share for $4,710,225 gross ($3,940,000 net), placed by ThinkEquity LLC. Dilution here is driven primarily by S-3 shelf 333-276650, registered to $200,000,000, with $22,110,225 used to date and $177,889,775 remaining, of which $6,456,442 is currently available under I.B.6; it expires 2027-01-31.